AtriCure Inc. (ATRC) PT Raised to $65 by Stifel - Physicians Favor LAAM Technology

September 17, 2026 7:43 AM

Stifel analyst John McAulay reiterated a Buy rating and $65.00 price target on AtriCure Inc. (NASDAQ: ATRC).The analyst commented, "Since ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found